AQR Capital Management’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $723K | Sell |
1,012,716
-308,201
| -23% | -$220K | ﹤0.01% | 2400 |
|
|
2025
Q1 | $859K | Buy |
1,320,917
+1,206,330
| +1,053% | +$785K | ﹤0.01% | 2126 |
|
|
2024
Q4 | $211K | Sell |
114,587
-210,951
| -65% | -$388K | ﹤0.01% | 2656 |
|
|
2024
Q3 | $1.13M | Buy |
325,538
+42,022
| +15% | +$145K | ﹤0.01% | 1776 |
|
|
2024
Q2 | $831K | Buy |
283,516
+247,694
| +691% | +$726K | ﹤0.01% | 1835 |
|
|
2024
Q1 | $202K | Sell |
35,822
-47,804
| -57% | -$270K | ﹤0.01% | 2249 |
|
|
2023
Q4 | $359K | Buy |
83,626
+59,868
| +252% | +$257K | ﹤0.01% | 2003 |
|
|
2023
Q3 | $82.4K | Sell |
23,758
-57,943
| -71% | -$201K | ﹤0.01% | 2248 |
|
|
2023
Q2 | $380K | Sell |
81,701
-311,995
| -79% | -$1.45M | ﹤0.01% | 1864 |
|
|
2023
Q1 | $1.82M | Buy |
393,696
+195,590
| +99% | +$904K | ﹤0.01% | 1297 |
|
|
2022
Q4 | $1.6M | Buy |
198,106
+6,030
| +3% | +$48.7K | ﹤0.01% | 1354 |
|
|
2022
Q3 | $1.07M | Buy |
192,076
+132,679
| +223% | +$736K | ﹤0.01% | 1493 |
|
|
2022
Q2 | $309K | Buy |
59,397
+36,221
| +156% | +$188K | ﹤0.01% | 1860 |
|
|
2022
Q1 | $191K | Buy |
+23,176
| New | +$191K | ﹤0.01% | 2074 |
|
|
2021
Q4 | – | Sell |
-14,519
| Closed | -$274K | – | 2274 |
|
|
2021
Q3 | $274K | Buy |
+14,519
| New | +$274K | ﹤0.01% | 2060 |
|
|
2021
Q2 | – | Sell |
-42,670
| Closed | -$971K | – | 2296 |
|
|
2021
Q1 | $971K | Buy |
42,670
+27,661
| +184% | +$629K | ﹤0.01% | 1563 |
|
|
2020
Q4 | $326K | Buy |
+15,009
| New | +$326K | ﹤0.01% | 1943 |
|